HISTORY OF OUR COMPANY The Greater Cannabis Company, Inc. (the Company ) was formed in March 2014 as a limited liability company under the name, The Greater Cannabis Company, LLC. The Company was a wholly owned subsidiary of Sylios Corp ( Sylios ) until March 10, 2017.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
$880K
▼ -85.2% YoY
Op. Margin
–
ROIC
-3123.27%
▼ -96.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$41K
▲ +45.1% YoY
Net Debt
-$111.00
Net Cash Position
Cash & Equiv.
$111.00
3Y CAGR: -49.0%
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with GCAN
Greater Cannabis Company (GCAN) in three numbers
Questions about Greater Cannabis Company
Is Greater Cannabis Company (GCAN) overvalued?
Greater Cannabis Company trades at 0.72 times earnings. Intrinsiqq's fair value calculator has no opening value for GCAN, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Is Greater Cannabis Company a high-quality business?
Greater Cannabis Company scores 20 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is net debt at -$111, and its weakest is return on capital at -3123.3%. The Quality tab shows every check against its target.
Does Greater Cannabis Company (GCAN) pay a dividend?
No. Greater Cannabis Company (GCAN) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 14 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 3 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in GCAN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GCAN
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.